Albunorm 40 g/l infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

albunorm 40 g/l infuusioneste, liuos

octapharma ab - albumin, human - infuusioneste, liuos - 40 g/l - albumiini

Albumin Behring 200 g/l infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

albumin behring 200 g/l infuusioneste, liuos

csl behring gmbh - albumin, human - infuusioneste, liuos - 200 g/l - albumiini

Comirnaty Euroopan unioni - suomi - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

octaplasLG infuusiokuiva-aine ja liuotin, liuosta varten Suomi - suomi - Fimea (Suomen lääkevirasto)

octaplaslg infuusiokuiva-aine ja liuotin, liuosta varten

octapharma ab - plasma protein human - infuusiokuiva-aine ja liuotin, liuosta varten - veren korvikkeet ja plasman proteiinifraktiot

Octanine 100 IU/ml injektiokuiva-aine ja liuotin, liuosta varten Suomi - suomi - Fimea (Suomen lääkevirasto)

octanine 100 iu/ml injektiokuiva-aine ja liuotin, liuosta varten

octapharma ab - human coagulation factor ix - injektiokuiva-aine ja liuotin, liuosta varten - 100 iu/ml - hyytymistekijä ix

HUMAN ALBUMIN BAXTER 200 mg/ml infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

human albumin baxter 200 mg/ml infuusioneste, liuos

baxter ag - albuminum ihmisen - infuusioneste, liuos - 200 mg/ml - albumiini

Wilfactin 100 IU/ml injektiokuiva-aine ja liuotin, liuosta varten Suomi - suomi - Fimea (Suomen lääkevirasto)

wilfactin 100 iu/ml injektiokuiva-aine ja liuotin, liuosta varten

lfb biomedicaments - human von willebrand factor - injektiokuiva-aine ja liuotin, liuosta varten - 100 iu/ml - von willebrand -tekijä

Gamunex 100 mg/ml infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

gamunex 100 mg/ml infuusioneste, liuos

grifols deutschland gmbh - human normal immunoglobulin - infuusioneste, liuos - 100 mg/ml - ihmisen normaali immunoglobuliini intravaskulaariseen käyttöön

Iqymune 100 mg/ml infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

iqymune 100 mg/ml infuusioneste, liuos

laboratoire francais du fractionnement et des biotechnologies - human normal immunoglobulin - infuusioneste, liuos - 100 mg/ml - ihmisen normaali immunoglobuliini intravaskulaariseen käyttöön

Cuvitru 200 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

cuvitru 200 mg/ml injektioneste, liuos

baxalta innovations gmbh - human normal immunoglobulin - injektioneste, liuos - 200 mg/ml - ihmisen normaali immunoglobuliini ekstravaskulaariseen käyttöön